GlassScriptPhysician profile
Wesley H Barry
NPI 1477662617
$5,013.40
in general payments reported to CMS, 2019-2025
25 companies · $50.34 in 2025
The $50.34 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,197 · 2020: $121 · 2021: $328 · 2022: $123 · 2023: $2,065 · 2024: $129 · 2025: $50.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,353 · Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,352.89 |
| Food and Beverage | $891.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,896.75 | 2019-2023 | Grafix Pl, Oasis, Grafix |
| Allergan, INC. | $1,611.95 | 2019-2022 | |
| Intuitive Surgical, INC. | $338.34 | 2019-2023 | Da Vinci Surgical System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.49 | 2019 | |
| Becton, Dickinson and Company | $125.06 | 2019 | |
| Davol INC. | $123.26 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $105.84 | 2022-2024 | Nuzyra |
| Integra Lifesciences Corporation | $90.30 | 2020-2022 | |
| Medtronic, INC. | $80.80 | 2021 | |
| Boston Scientific Corporation | $76.24 | 2019 | |
| Zimmer Biomet Holdings, INC. | $68.37 | 2023 | |
| Conmed Corporation | $62.50 | 2019 | |
| Medtronic USA, INC. | $52.71 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $44.99 | 2024-2025 | |
| Ethicon US, LLC | $27.97 | 2020-2025 | Surgicel Nu-Knit, Evarrest |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.18 | 2021 | |
| Tela Bio, INC. | $22.62 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $22.22 | 2024 | |
| Acell, INC. | $21.76 | 2020 | |
| Baudax Bio INC. | $15.20 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.45 | 2025 | Gattex |
| Kowa Pharmaceuticals America, INC. | $14.35 | 2023 | Seglentis |
| Asensus Surgical, INC. | $14.13 | 2019 | |
| Kerecis Limited | $13.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Cook Medical LLC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.